Frank Douglas is the president and CEO of Austen BioInnovation Institute in Akron, Ohio, a best-in-class model for the future of health care delivery and innovation. Douglas, a former founder and executive director of Massachusetts Institute of Technology’s Center of Biomedical Innovation, is an award-winning industry veteran, with more than twenty-four years of experience in health care, pharmaceutical research, and biotechnology.
Douglas joined the Austen BioInnovation Institute in Akron after serving as senior partner, Puretech Ventures and, chief scientific advisor, Bayer Healthcare, AG.
Douglas has received more than fifteen industry awards, including the Global Pharmaceutical Chief Scientific Officer of the Year Award, the Wolfgang von Goethe Medal of Honor, the Associated Black Charities’ Black History Makers Award, the Lifetime Achievement Award from the National Organization of Black Chemists and Chemical Engineers, and the Heart of the Year Award from the Chicago Heart Association and the Louis B. Russell Memorial Award from the American Heart Association, both for his development of high blood pressure screening and control programs for African-American churches in Chicago.
After graduating cum laude from Lehigh University, Douglas attended Cornell University where he earned his PhD in physical chemistry and his MD. He completed his internship and residency in internal medicine at The Johns Hopkins Medical Institutions and a fellowship in neuroendocrinology at the National Institutes of Health.